Statement regarding Canadian CCSVI Trials
4th July, 2011
The Canadian Government recently announced they will be funding future Phase I and II clinical trials into chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis (MS).
This is of interest to many Australians who live with MS.
It is our understanding that these trials will examine the merit of a procedure to treat CCSVI and its potential relationship with treatment of MS.
As MSRA understands it, the Canadian government has based their decision to fund these trials on data that has recently been presented to them in confidence. The data is reported to be a meta-analysis that combines the data from a number of different studies on the prevalence of CCSVI in MS to provide a collective statistical analysis of the results. This data is not publicly available as it has not yet been published in a peer-reviewed journal.
MS Australia supports research into the cause and cure of multiple sclerosis and through MS Research Australia we are also studying a particular aspect of the link between CCSVI and MS. Please click here for information regarding this study.
We also recognise the importance of global research into the disease as one that affects people around the world, and we eagerly await the research findings from the Canadian trials. We also await results from the other rigorous studies currently running in the USA and Canada investigating the prevalence of CCSVI in people with MS. The USA and Canadian MS societies provided $2.4 million in funding for these studies, which will provide valuable insight into the role that CCSVI plays in MS. Further information on these studies can be found here.
MS Research Australia urges people with MS to contact their treating Health Care Practitioner or Neurologist for advice.